EP Patent

EP0632048A1 — Phosphonate-nucleotide ester derivatives

Assigned to Mitsubishi Chemical Corp · Expires 1995-01-04 · 31y expired

What this patent protects

Phosphonate-nucleotide ester derivatives of the present invention have excellent antiviral activity and activity. Further, it can be orally administered.

USPTO Abstract

Phosphonate-nucleotide ester derivatives of the present invention have excellent antiviral activity and activity. Further, it can be orally administered.

Drugs covered by this patent

Patent Metadata

Patent number
EP0632048A1
Jurisdiction
EP
Classification
—
Expires
1995-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Mitsubishi Chemical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.